Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ORBIT-AMD: Ordinal Risk, Bilateral Imaging, and Trajectory Learning for Age-Related Macular Degeneration in Multi-Cohorts.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Cathepsin H drives hypoxia-associated inflammatory and angiogenic programs in diabetic retinopathy and represents a potential therapeutic target.

International journal of biological sciences·2026
Same author

Integrated plasma proteomics and metabolomics reveal immunometabolic pathways and predictive signatures for age-related eye diseases.

Metabolism: clinical and experimental·2026
Same author

Omics in hereditary optic neuropathies: A systematic review of clinical studies with an integrated point of view.

Survey of ophthalmology·2026
Same author

Sleep Regularity and Age-Related Eye Diseases: Prospective Analyses with Retinal Imaging and Multimorbidity Assessment in the UK Biobank.

Sleep·2026
Same author

Efficacy of lenadogene nolparvovec gene therapy versus idebenone in Leber hereditary optic neuropathy due to the m.11778G>A <i>MT-ND4</i> variant: two matching adjusted indirect comparisons.

The British journal of ophthalmology·2026
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Related Experiment Video

Updated: Jun 5, 2026

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

Steroids for traumatic optic neuropathy.

Patrick Yu-Wai-Man1, Philip G Griffiths

  • 1Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne, UK, NE1 4LP.

The Cochrane Database of Systematic Reviews
|January 21, 2011
PubMed
Summary
This summary is machine-generated.

Steroids do not appear to improve vision in traumatic optic neuropathy (TON). Further research is needed as steroids may even harm vision in TON patients.

More Related Videos

A Surgical Approach for Optic Nerve Crush in a Rabbit Model
06:15

A Surgical Approach for Optic Nerve Crush in a Rabbit Model

Published on: July 8, 2025

System for Focal, Closed-System Central Nervous System Injury
04:02

System for Focal, Closed-System Central Nervous System Injury

Published on: November 29, 2024

Related Experiment Videos

Last Updated: Jun 5, 2026

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

A Surgical Approach for Optic Nerve Crush in a Rabbit Model
06:15

A Surgical Approach for Optic Nerve Crush in a Rabbit Model

Published on: July 8, 2025

System for Focal, Closed-System Central Nervous System Injury
04:02

System for Focal, Closed-System Central Nervous System Injury

Published on: November 29, 2024

Area of Science:

  • Ophthalmology
  • Neurology

Background:

  • Traumatic optic neuropathy (TON) causes severe vision loss after head trauma.
  • Optic nerve swelling can lead to secondary retinal ganglion cell loss.
  • Interventions like steroids and surgery are used to improve visual prognosis in TON.

Purpose of the Study:

  • To review the effectiveness and safety of steroid use in traumatic optic neuropathy (TON).

Main Methods:

  • Systematic review of randomized controlled trials (RCTs) comparing steroids with surgery or no treatment.
  • Searched multiple databases (CENTRAL, MEDLINE, EMBASE, LILACS, mRCT, ClinicalTrials.gov, Web of Science) up to November 2010.
  • Included one double-masked, placebo-controlled RCT with 31 participants.

Main Results:

  • The single RCT found no statistically significant difference in visual acuity between steroid and placebo groups.
  • Visual recovery occurred in 53.3% of the placebo group and 68.8% of the steroid group, a non-significant difference.
  • The mean difference in visual acuity was 0.67 LogMAR, not reaching statistical significance.

Conclusions:

  • There is a high rate of spontaneous visual recovery in TON.
  • Current evidence does not convincingly show additional visual benefit from steroids over observation.
  • Potential detrimental effects of steroids warrant further investigation; individual assessment and informed consent are crucial.